Skip to main content
. 2020 Oct 7;77(3):409–419. doi: 10.1007/s00228-020-03015-7

Fig. 2.

Fig. 2

Adjusted hazard ratios of outcomes related to co-treatment with NOACs and interacting drugs with pharmacodynamic effect, compared with NOACs without the interacting drug group